MENU
+Compare
IXHL
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$0.36
Change
-$0.01 (-2.70%)
Capitalization
124.17M

IXHL Incannex Healthcare Forecast, Technical & Fundamental Analysis

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions... Show more

IXHL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IXHL with price predictions
Nov 12, 2025

Momentum Indicator for IXHL turns positive, indicating new upward trend

IXHL saw its Momentum Indicator move above the 0 level on November 10, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator turned positive. In of the 54 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IXHL's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where IXHL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IXHL just turned positive on October 28, 2025. Looking at past instances where IXHL's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXHL advanced for three days, in of 181 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXHL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IXHL entered a downward trend on November 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.276) is normal, around the industry mean (18.827). P/E Ratio (0.000) is within average values for comparable stocks, (71.764). IXHL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). IXHL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (142.857) is also within normal values, averaging (39.291).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IXHL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IXHL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
IXHL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
8 Century Circuit Norwest
Phone
+61 425703805
Employees
10
Web
https://www.incannex.com.au
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKHHF69.75N/A
N/A
Heineken Holding N.V.
SENR0.05N/A
N/A
Strategic Environmental & Energy Resources, Inc.
TWIRF1.96N/A
N/A
Tree Island Steel Ltd.
WNDLF90.56N/A
N/A
Wendel
XVIPF17.46N/A
N/A
Xvivo Perfusion AB

IXHL and Stocks

Correlation & Price change

A.I.dvisor tells us that IXHL and INM have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IXHL and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
+3.50%
INM - IXHL
33%
Poorly correlated
-0.57%
ESPR - IXHL
23%
Poorly correlated
-2.26%
NBIX - IXHL
22%
Poorly correlated
-0.30%
HROW - IXHL
22%
Poorly correlated
-0.77%
YCBD - IXHL
20%
Poorly correlated
-3.72%
More

Groups containing IXHL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IXHL
1D Price
Change %
IXHL100%
+3.50%
Pharmaceuticals: Generic
industry (214 stocks)
-6%
Poorly correlated
-1.00%